Showing results (21-30 of 30) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Plos Pathogens|May 18, 2023
Enhanced stability of the SARS CoV-2 spike glycoprotein following modification of an alanine cavity in the protein corePantelis Poumbourios, Christine Langer, Irene Boo, et al.Journal of Clinical Immunology|June 15, 2023
COVID-19 Adenoviral Vector Vaccination Elicits a Robust Memory B Cell Response with the Capacity to Recognize Omicron BA.2 and BA.5 VariantsHolly A Fryer, Gemma E Hartley, Emily S J Edwards, et al.NPJ Vaccines|July 16, 2024
Homologous but not heterologous COVID-19 vaccine booster elicits IgG4+ B-cells and enhanced Omicron subvariant bindingGemma E Hartley, Holly A Fryer, Paul A Gill, et al.Journal of Hepatology|December 1, 2019
B cell immunodominance in primary hepatitis C virus infectionNicholas A Brasher, Auda A Eltahla, Alexander Underwood, et al.Science Immunology|January 14, 2021
Rapid generation of durable B cell memory to SARS-CoV-2 spike and nucleocapsid proteins in COVID-19 and convalescenceGemma E Hartley, Emily S J Edwards, Pei M Aui, et al.Frontiers in Immunology|February 29, 2024
Injecting drug use and hepatitis C virus infection independently increase biomarkers of inflammatory disease risk which are incompletely restored by curative direct-acting antiviral therapyAnna C Hearps, Nikil Vootukuru, Salimeh Ebrahimnezhaddarzi, et al.Immunology and Cell Biology|August 18, 2023
Serological assays to measure dimeric IgA antibodies in SARS-CoV-2 infectionsZihui Wei, Fiona Angrisano, Emily M Eriksson, et al.Medrxiv : the Preprint Server for Health Sciences|July 7, 2021
Dimeric IgA is a specific biomarker of recent SARS-CoV-2 infectionHeidi E Drummer, Huy Van, Ethan Klock, et al.Journal of Hepatology|April 11, 2024
B-cell characteristics define HCV reinfection outcomeAlexander P Underwood, Money Gupta, Bing-Ru Wu, et al.Ebiomedicine|December 6, 2021
A point-of-care lateral flow assay for neutralising antibodies against SARS-CoV-2Thomas S Fulford, Huy Van, Nicholas A Gherardin, et al.Pageof 3